A proposal for an updated neuropsychopharmacological nomenclature
Open Access
- 1 July 2014
- journal article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 24 (7) , 1005-1014
Abstract
No abstract availableKeywords
Funding Information
- ECNP
This publication has 10 references indexed in Scilit:
- Poster #209 CENTRAL GLYCINE INCREASE IN RATS, MONKEYS AND HEALTHY VOLUNTEERS AFTER TWO GLYCINE REUPTAKE INHIBITORS, RG1678 AND RG7118Schizophrenia Research, 2012
- Pharmacological Effects of Lu AA21004: A Novel Multimodal Compound for the Treatment of Major Depressive DisorderThe Journal of Pharmacology and Experimental Therapeutics, 2012
- Glycine reuptake inhibitor RG1678: A pharmacologic characterization of an investigational agent for the treatment of schizophreniaNeuropharmacology, 2012
- Antipsychotics in anxiety disorders: An oxymoron or a reflection of non-adequate nomenclature?European Neuropsychopharmacology, 2011
- Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive DisorderJournal of Medicinal Chemistry, 2011
- Research Domain Criteria (RDoC): Toward a New Classification Framework for Research on Mental DisordersAmerican Journal of Psychiatry, 2010
- Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive DisorderThe Journal of Clinical Psychiatry, 2009
- The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive DisorderThe Journal of Clinical Psychiatry, 2007
- A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine, and Fluoxetine in Treatment-Resistant Major Depressive DisorderThe Journal of Clinical Psychiatry, 2007
- Serotonergic Responsivity in Obsessive-Compulsive DisorderArchives of General Psychiatry, 1987